☰ Chemistry Tree

Yu Joshua Cao

Affiliations:	2013-2016	Chemistry	Scripps Research Institute, La Jolla, La Jolla, CA, United States
	2017-	Chemical Biology and Biotechnology	Peking University Shenzhen Graduate School

Google:

Mean distance: (not calculated yet)

Tree Publications Similar researchers PubMed Report error

Parents

Gang Bai	grad student	2001-2007	Nankai University
Michael G. Rosenblum	grad student	2007-2013	University of Texas, MD Anderson Cancer Center
Peter G. Schultz	post-doc	2013-2016	Scripps Institute

Children

Zhidong Wang	grad student	2018-2022	Peking University
Lijun Zhao	grad student	2018-2022	Peking University
Shuhong Li	grad student	2019-2023	Peking University

Collaborators

BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.
He M, Zhang D, Cao Y, et al. (2023) Chimeric antigen receptor-modified T cells therapy in prostate cancer: A comprehensive review on the current state and prospects. Heliyon. 9: e19147
Cao Y, Efetov SK, He M, et al. (2023) Updated Clinical Perspectives and Challenges of Chimeric Antigen Receptor-T Cell Therapy in Colorectal Cancer and Invasive Breast Cancer. Archivum Immunologiae Et Therapiae Experimentalis. 71: 19
Wen J, Huang Q, Yao J, et al. (2023) Focusing on scRNA-seq-Derived T Cell-Associated Genes to Identify Prognostic Signature and Immune Microenvironment Status in Low-Grade Glioma. Mediators of Inflammation. 2023: 3648946
Jiang H, Suo H, Gao L, et al. (2023) Metformin plays an antitumor role by downregulating inhibitory cells and immune checkpoint molecules while activating protective immune responses in breast cancer. International Immunopharmacology. 118: 110038
Qiu Y, Qi Z, Wang Z, et al. (2022) EGF‑IL2 bispecific and bivalent EGF fusion toxin efficacy against syngeneic head and neck cancer mouse models. Oncology Reports. 49
Liu D, Qi X, Wei X, et al. (2022) A Novel Her2/VEGFR2/CD3 trispecific antibody with an optimal structural design showed improved T-cell-redirecting antitumor efficacy. Theranostics. 12: 7788-7803
Zhao L, Li S, Wei X, et al. (2022) A novel CD19/CD22/CD3 trispecific antibody enhances therapeutic efficacy and overcomes immune escape against B-ALL. Blood
Xia Y, Li X, Yang L, et al. (2021) Development of thermostable sucrose phosphorylase by semi-rational design for efficient biosynthesis of alpha-D-glucosylglycerol. Applied Microbiology and Biotechnology
Cao YJ, Yu C, Wu KL, et al. (2021) Synthesis of precision antibody conjugates using proximity-induced chemistry. Theranostics. 11: 9107-9117
Bloom JA, Sekigami Y, Young R, et al. (2021) Discordance in Oncotype DX Breast Recurrence Score Results for Bilateral Breast Cancer. Annals of Surgical Oncology

See more...